Vitarka Therapeutics develops medical technology and solutions for various types of cancer.
Vitarka Therapeutics's investors include Future Planet Capital, SOSV, Innovate UK, SOSV SF & NY (Fka IndieBio), UK Innovation & Science Seed Fund.
Vitarka Therapeutics is headquartered in London, United Kingdom.
Vitarka Therapeutics develops medical technology and solutions for various types of cancer.
Vitarka Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vitarka Therapeutics — Funding & Investors." VCBacked, December 6, 2024, https://www.vcbacked.co/company/vitarka-therapeutics. Accessed November 14, 2026.
VCBacked. (2024). Vitarka Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/vitarka-therapeutics
{{cite web |title=Vitarka Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vitarka-therapeutics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Vitarka Therapeutics? Request a listing update